Hot Features
프리미엄
Biomea Fusion Inc (BMEA)
NASDAQ
실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. 더 보기
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.65 | -18.1058495822 | 3.59 | 3.75 | 2.8 | 517910 | 3.12214415 | CS |
| 4 | -1.3 | -30.6603773585 | 4.24 | 4.43 | 2.8 | 461998 | 3.60918045 | CS |
| 12 | -4.035 | -57.8494623656 | 6.975 | 7.06 | 2.8 | 786456 | 4.31935342 | CS |
| 26 | -4.88 | -62.4040920716 | 7.82 | 13.07 | 2.8 | 768413 | 6.95530984 | CS |
| 52 | -13.07 | -81.6364772017 | 16.01 | 19.3549 | 2.8 | 965776 | 8.40448155 | CS |
| 156 | -3.83 | -56.5731166913 | 6.77 | 43.69 | 2.8 | 665345 | 14.28934376 | CS |
| 260 | -17.06 | -85.3 | 20 | 43.69 | 2.8 | 547182 | 14.1606899 | CS |
Monksdream
6 월 전
Zraced1
9 월 전
giveit2me
1 년 전
Invest-in-America
2 년 전
Invest-in-America
2 년 전
TheFinalCD
2 년 전
Invest-in-America
2 년 전
Bbradley8
2 년 전
